TABLE 1.
Reasons for treatment in participants who had undergone definitive treatment after active surveillance (AS)
| Reason item | N | Doesn't apply. N (%) | Minimally/Somewhat applies. N (%) | Very much/Strongly applies. N (%) | Mean (SD) |
|---|---|---|---|---|---|
| Medical reasons | |||||
| PSA increase | 50 | 2 (4%) | 13 (26%) | 35 (70%) | 4 (1) |
| Doctor recommendation | 48 | 4 (8.3%) | 10 (20.8%) | 34 (70.8%) | 3.9 (1.2) |
| Biopsy | 46 | 6 (13.1%) | 11 (23.9%) | 29 (63%) | 3.6 (1.3) |
| Gleason score increase | 45 | 12 (26.7%) | 6 (13.3%) | 27 (60%) | 3.3 (1.6) |
| DRE | 44 | 37 (84.1%) | 3 (6.8%) | 4 (9.1%) | 1.4 (1) |
| Medical comorbidities | 43 | 32 (74.4%) | 7 (16.3%) | 4 (9.3%) | 1.6 (1.2) |
| Personal reasons | |||||
| Desire to act | 47 | 13 (27.7%) | 10 (21.3%) | 24 (51.1%) | 3.2 (1.6) |
| Fear of cancer | 44 | 28 (63.6%) | 8 (18.2%) | 8 (18.2%) | 1.9 (1.3) |
| Pressure from others | 46 | 29 (63%) | 10 (21.7%) | 7 (15.2%) | 1.9 (1.3) |
| Uncertainty | 40 | 27 (67.5%) | 9 (22.5%) | 4 (10%) | 1.7 (1.1) |
| Anxiety | 45 | 34 (75.6%) | 10 (22.2%) | 1 (2.2%) | 1.4 (0.8) |
| Tired of waiting | 42 | 33 (78.6%) | 7 (16.7%) | 2 (4.8%) | 1.4 (0.9) |
| Inconvenient protocol | 43 | 39 (90.7%) | 4 (9.3%) | 0 (0%) | 1.1 (0.4) |
| Depression | 43 | 39 (90.7%) | 4 (9.3%) | 0 (0%) | 1.1 (0.5) |